Featured Research

from universities, journals, and other organizations

Predicting which HIV patients will respond better to future therapeutic vaccine

Date:
July 17, 2014
Source:
University of St George's London
Summary:
HIV patients with a higher level of a particular biomarker, or a measurable indicator found in the blood, may respondmore favorably to an experimental immune activating vaccine, a study suggests. Experts believe the findings might lead to a more customized vaccine for certain patients, which potentially might permit them to come off antiretrovirals, drugs used to treat HIV.

A new study suggests that HIV patients with a higher level of a particular biomarker, or a measurable indicator found in the blood, may respond more favourably to an experimental immune activating vaccine.

Experts at St George's, University of London, and Norwegian vaccine company, Bionor Pharma Researchers, believe the findings might lead to a more customized vaccine for certain patients, which potentially might permit them to come off antiretrovirals, drugs used to treat HIV.

The research found that the therapeutic vaccine, Vacc-4x, reduced the amount of virus circulating in the body by more than half in patients with higher levels of the particular biomarker compared to those with lower levels.

Professor Angus Dalgleish, of St George's, University of London, said: "In spite of very effective drugs against HIV these need to be taken daily and have significant side-effects.

"The ability to replace this daily medication with a vaccine that allows several months of being off medication, not to mention the enormous financial gains that would be delivered to health services, is a step closer with these preliminary results."

Further study will be needed to confirm the results

These new results were announce at the AIDS 2014 Conference in Melbourne, Australia.

The results come from a collaborative project between St George's, University of London and Bionor Pharma.

In the UK nearly 78,000 people were receiving specialist care for HIV in 2012.


Story Source:

The above story is based on materials provided by University of St George's London. Note: Materials may be edited for content and length.


Cite This Page:

University of St George's London. "Predicting which HIV patients will respond better to future therapeutic vaccine." ScienceDaily. ScienceDaily, 17 July 2014. <www.sciencedaily.com/releases/2014/07/140717212148.htm>.
University of St George's London. (2014, July 17). Predicting which HIV patients will respond better to future therapeutic vaccine. ScienceDaily. Retrieved September 19, 2014 from www.sciencedaily.com/releases/2014/07/140717212148.htm
University of St George's London. "Predicting which HIV patients will respond better to future therapeutic vaccine." ScienceDaily. www.sciencedaily.com/releases/2014/07/140717212148.htm (accessed September 19, 2014).

Share This



More Health & Medicine News

Friday, September 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com
How The 'Angelina Jolie Effect' Increased Cancer Screenings

How The 'Angelina Jolie Effect' Increased Cancer Screenings

Newsy (Sep. 19, 2014) Angelina's Jolie's decision to undergo a preventative mastectomy in 2013 inspired many women to seek early screenings for the disease. Video provided by Newsy
Powered by NewsLook.com
The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins